Exposure‐Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients

We report the population pharmacokinetic (PK) and exposure‐response analyses of a novel subcutaneous formulation of daratumumab (DARA) using data from 3 DARA subcutaneous monotherapy studies (PAVO Part 2, MMY1008, COLUMBA) and 1 combination therapy study (PLEIADES). Results were based on 5159 PK sam...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Pharmacol
Auteurs principaux: Luo, Man (Melody), Usmani, Saad Z., Mateos, Maria‐Victoria, Nahi, Hareth, Chari, Ajai, San‐Miguel, Jesus, Touzeau, Cyrille, Suzuki, Kenshi, Kaiser, Martin, Carson, Robin, Heuck, Christoph, Qi, Ming, Zhou, Honghui, Sun, Yu‐Nien, Parasrampuria, Dolly A.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Exposure Response
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8048619/
https://ncbi.nlm.nih.gov/pubmed/33145788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1771
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires